Skin of Color Symposium: Dermatology Pearls for Treating Pediatric Patients of Color
Pediatric patients with melanin-rich skin, or skin of color (SOC), can be disproportionately affected by numerous dermatologic conditions.
Category
  • LivDerm
  • TME
Format
  • Video
Credits
  • 1.75 AAPA Category I CME
  • 1.75 AMA PRA Category 1 Credit™
  • 1.75 ANCC
  • 1.75 Participation
Clinical Brief: IL-13 inhibitors: Advances and Considerations for Managing Moderate-to-Severe Atopic Dermatitis
Timely and adequ
Category
  • LivDerm
  • TME
Format
  • Self-study / Enduring
Credits
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC
  • 0.25 Participation
Webcast Series: Optimizing Long-Term Weight Loss in Patients with Type 2 Diabetes: Advances and Expert Perspectives
The increasing prevalence and impacts of overweight and obesity in patients with type 2 diabetes renders weight loss and weight loss maintenance an important part of treatment goals. In this 6-part webcast series, chaired by Robert H.
Category
  • CMHC
  • TME
Format
  • Webinar recorded
Credits
Digital Pathway - The Evolving Landscape of LDL-C Reduction in High Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk
Lowering LDL-C effectively and safely is paramount to prevent and lower the risk of recurrent ASCVD events.
Category
  • CMHC
Format
  • Monograph
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
Webcast: Screening, Diagnosis and Treatment of IDA in NDD-CKD
Iron deficiency anemia (IDA) is a common condition in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) that can affect quality of life and lead to suboptimal outcomes.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
Webcast: Challenging Cases in NDD-CKD patients with IDA
Iron deficiency anemia (IDA) is the most common cause of anemia in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) and addressing this condition is important in the overall management of these patients.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
Hunting for Better Outcomes: Management Options for Huntington’s Disease
Huntington’s disease (HD) is a rare, progressive, genetic disorder resulting in a breakdown of nerve cells in the brain. Many types of clinicians are involved in the patient journey because HD affects movement, behavior, memory loss, impulse control, and the ability to do the simplest self-care activities. This multimedia activity provides the collaborative care team of neurologists, psychiatrists, and allied healthcare providers with an improved understanding of the fundamentals of HD, its chronic burden, and how to treat patients accordingly. Hunting for Better Outcomes provides HCPs with an enhanced understanding of HD and tools for improving overall patient outcomes.
Category
Format
Credits
  • 0.50 ACCME (All Other)
  • 0.50 ACCME (MD/DO Only)
  • 0.50 ACPE Pharmacy
  • 0.50 ANCC
Webcast: Challenging Cases in Lipid Lowering: Interpreting the Evidence to Patient Care
Expert faculty developed three challenging cases that illustrate practical points about the current challenges of optimizing LDL-C lowering therapy, as well as how to optimize treatment with statin and non-statin therapies.
Category
  • CMHC
Format
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
Virtual Symposium - Optimizing Lipid Lowering Therapy in Women: Gaps, Perspectives, and Advances
Atherosclerotic cardiovascular disease (ASCVD) events are among the leading causes of death in women in the US and globally.
Category
  • CMHC
Format
  • Video
Credits
  • 0.75 ACPE Pharmacy
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
Webcast: Optimizing LDL-C Management Post-MI: Patient Case & Expert Discussions
Expert faculty developed challenging cases to illustrate practical points in the optimization of LDL-C therapy post-MI, including, but not limited to the points illustrated below. At the end of each case, faculty engage in discussions to offer clinical pearls and expert insights on the cases.
Category
  • CMHC
Format
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation

Pages